☰

Taleen Hanania - Publications

Affiliations: 
PsychoGenics Inc, Tarrytown, NY, United States 
Area:
CNS disorders
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Kabitzke P, Morales D, He D, Cox K, Sutphen J, Thiede L, Sabath E, Hanania T, Biemans B, Brunner D. Mouse Model Systems of Autism Spectrum Disorder: Replicability and Informatics Signature. Genes, Brain, and Behavior. e12676. PMID 32445272 DOI: 10.1111/Gbb.12676  0.32
2019 Kaufmann WE, Sprouse J, Rebowe N, Hanania T, Klamer D, Missling CU. ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome. Pharmacology, Biochemistry, and Behavior. 187: 172796. PMID 31704481 DOI: 10.1016/j.pbb.2019.172796  0.366
2019 Dedic N, Jones PG, Hopkins SC, Lew R, Shao L, Campbell JE, Spear KL, Large TH, Campbell UC, Hanania T, Leahy E, Koblan K. SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A UNIQUE, NON-D2 RECEPTOR MECHANISM OF ACTION. The Journal of Pharmacology and Experimental Therapeutics. PMID 31371483 DOI: 10.1124/jpet.119.260281  0.38
2017 Kabitzke P, Brunner D, He D, Fazio PA, Cox K, Sutphen J, Thiede L, Sabath E, Hanania T, Alexandrov V, Rasmusson R, Spooren W, Ghosh A, Feliciano P, Biemans B, et al. Comprehensive Analysis of Two Shank3 and the Cacna1c Mouse Models of Autism Spectrum Disorder. Genes, Brain, and Behavior. PMID 28753255 DOI: 10.1111/Gbb.12405  0.324
2016 Shao L, Campbell UC, Fang QK, Powell NA, Campbell JE, Jones PG, Hanania T, Alexandrov V, Morganstern I, Sabath E, Zhong HM, Large TH, Spear KL. In vivo phenotypic drug discovery: Applying a behavioral assay to the discovery and optimization of novel antipsychotic agents Medchemcomm. 7: 1093-1101. DOI: 10.1039/c6md00128a  0.323
2015 Brunner D, Kabitzke P, He D, Cox K, Thiede L, Hanania T, Sabath E, Alexandrov V, Saxe M, Peles E, Mills A, Spooren W, Ghosh A, Feliciano P, Benedetti M, et al. Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder. Plos One. 10: e0134572. PMID 26273832 DOI: 10.1371/Journal.Pone.0134572  0.339
2015 Henry MA, Fairchild DD, Patil MJ, Hanania T, Hain HS, Davis SF, Malekiani SA, Hu A, Sucholeiki R, Nix D, Sucholeiki I. Effect of a Novel, Orally Active Matrix Metalloproteinase-2 and -9 Inhibitor in Spinal and Trigeminal Rat Models of Neuropathic Pain. Journal of Oral & Facial Pain and Headache. 29: 286-96. PMID 26244437 DOI: 10.11607/Ofph.1350  0.306
2015 Chang Q, Hanania T, Mash DC, Maillet EL. Noribogaine reduces nicotine self-administration in rats. Journal of Psychopharmacology (Oxford, England). 29: 704-11. PMID 25995321 DOI: 10.1177/0269881115584461  0.337
2015 Alexandrov V, Brunner D, Hanania T, Leahy E. Reprint of: Highthroughtput analysis of behavior for drug discovery. European Journal of Pharmacology. 753: 127-34. PMID 25744878 DOI: 10.1016/J.Ejphar.2015.02.037  0.32
2015 Alexandrov V, Brunner D, Hanania T, Leahy E. High-throughput analysis of behavior for drug discovery. European Journal of Pharmacology. 750: 82-9. PMID 25592319 DOI: 10.1016/J.Ejphar.2014.11.047  0.321
2014 Yu LF, Brek Eaton J, Zhang HK, Sabath E, Hanania T, Li GN, van Breemen RB, Whiteaker P, Liu Q, Wu J, Chang YC, Lukas RJ, Brunner D, Kozikowski AP. The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile. Pharmacology Research & Perspectives. 2: e00026. PMID 25505580 DOI: 10.1002/Prp2.26  0.41
2013 Hanson JE, La H, Plise E, Chen YH, Ding X, Hanania T, Sabath EV, Alexandrov V, Brunner D, Leahy E, Steiner P, Liu L, Scearce-Levie K, Zhou Q. SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition. Plos One. 8: e69964. PMID 23922875 DOI: 10.1371/journal.pone.0069964  0.319
2013 Zhang HK, Yu LF, Eaton JB, Whiteaker P, Onajole OK, Hanania T, Brunner D, Lukas RJ, Kozikowski AP. Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part II. Journal of Medicinal Chemistry. 56: 5495-504. PMID 23734673 DOI: 10.1021/Jm400510U  0.39
2013 Gunosewoyo H, Midzak A, Gaisina IN, Sabath EV, Fedolak A, Hanania T, Brunner D, Papadopoulos V, Kozikowski AP. Characterization of maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitors as stimulators of steroidogenesis. Journal of Medicinal Chemistry. 56: 5115-29. PMID 23725591 DOI: 10.1021/Jm400511S  0.378
2012 Yu LF, Eaton JB, Fedolak A, Zhang HK, Hanania T, Brunner D, Lukas RJ, Kozikowski AP. Discovery of highly potent and selective α4β2-nicotinic acetylcholine receptor (nAChR) partial agonists containing an isoxazolylpyridine ether scaffold that demonstrate antidepressant-like activity. Part II. Journal of Medicinal Chemistry. 55: 9998-10009. PMID 23092294 DOI: 10.1021/Jm301177J  0.371
2012 Zhang HK, Eaton JB, Yu LF, Nys M, Mazzolari A, van Elk R, Smit AB, Alexandrov V, Hanania T, Sabath E, Fedolak A, Brunner D, Lukas RJ, Vistoli G, Ulens C, et al. Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands. Journal of Medicinal Chemistry. 55: 8028-37. PMID 22928944 DOI: 10.1021/Jm3008739  0.339
2012 Yu LF, Tückmantel W, Eaton JB, Caldarone B, Fedolak A, Hanania T, Brunner D, Lukas RJ, Kozikowski AP. Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity. Journal of Medicinal Chemistry. 55: 812-23. PMID 22148173 DOI: 10.1021/Jm201301H  0.409
2012 Paterson NE, Wetzler C, Hackett A, Hanania T. Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1473-87. PMID 22094071 DOI: 10.1017/S1461145711001635  0.377
2011 Roberds SL, Filippov I, Alexandrov V, Hanania T, Brunner D. Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms. Frontiers in Neuroscience. 5: 103. PMID 21927596 DOI: 10.3389/Fnins.2011.00103  0.386
2011 Vinkers CH, Olivier B, Hanania T, Min W, Schreiber R, Hopkins SC, Campbell U, Paterson N. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem. European Journal of Pharmacology. 668: 190-3. PMID 21762686 DOI: 10.1016/J.Ejphar.2011.06.054  0.383
2011 Caldarone BJ, Wang D, Paterson NE, Manzano M, Fedolak A, Cavino K, Kwan M, Hanania T, Chellappan SK, Kozikowski AP, Olivier B, Picciotto MR, Ghavami A. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380. Psychopharmacology. 217: 199-210. PMID 21487659 DOI: 10.1007/S00213-011-2271-Y  0.404
2011 Paterson NE, Ricciardi J, Wetzler C, Hanania T. Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. Neuroscience Research. 69: 41-50. PMID 20934466 DOI: 10.1016/j.neures.2010.10.001  0.327
2011 Paterson NE, Balci F, Campbell U, Olivier BE, Hanania T. The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition. Journal of Psychopharmacology (Oxford, England). 25: 1357-64. PMID 20305042 DOI: 10.1177/0269881110364272  0.345
2010 Paterson NE, Min W, Hackett A, Lowe D, Hanania T, Caldarone B, Ghavami A. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 1455-64. PMID 20708056 DOI: 10.1016/j.pnpbp.2010.07.037  0.339
2010 Paterson NE, Fedolak A, Olivier B, Hanania T, Ghavami A, Caldarone B. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents. Pharmacology, Biochemistry, and Behavior. 95: 449-56. PMID 20346966 DOI: 10.1016/J.Pbb.2010.03.006  0.326
2010 Paterson NE, Iwunze M, Davis SF, Malekiani SA, Hanania T. Comparison of the predictive validity of the mirror chamber and elevated plus maze tests in mice. Journal of Neuroscience Methods. 188: 62-70. PMID 20149823 DOI: 10.1016/j.jneumeth.2010.02.005  0.369
2010 Paterson NE, Hanania T. The modified Geller-Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation. Behavioural Brain Research. 208: 258-64. PMID 20006648 DOI: 10.1016/j.bbr.2009.12.006  0.389
2009 Paterson NE, Malekiani SA, Foreman MM, Olivier B, Hanania T. Pharmacological characterization of harmaline-induced tremor activity in mice. European Journal of Pharmacology. 616: 73-80. PMID 19497322 DOI: 10.1016/J.Ejphar.2009.05.031  0.394
2009 Foreman MM, Hanania T, Eller M. Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test. European Journal of Pharmacology. 602: 316-20. PMID 19038245 DOI: 10.1016/j.ejphar.2008.11.013  0.313
2009 Hackett A, Caldarone B, Kozikowski AP, Ghavami A, Olivier B, Hanania T, Paterson NE. The nAChR agonist AMOP-H-OH (‘sazetidine-A’) exhibits reinforcing, but not withdrawal-alleviating, properties in rats Biochemical Pharmacology. 78: 919. DOI: 10.1016/J.Bcp.2009.06.079  0.308
2008 Breuer ME, Chan JS, Oosting RS, Groenink L, Korte SM, Campbell U, Schreiber R, Hanania T, Snoeren EM, Waldinger M, Olivier B. The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 908-16. PMID 18789657 DOI: 10.1016/J.Euroneuro.2008.07.011  0.331
2008 Vinkers CH, van Bogaert MJ, Klanker M, Korte SM, Oosting R, Hanania T, Hopkins SC, Olivier B, Groenink L. Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm. European Journal of Pharmacology. 585: 407-25. PMID 18420191 DOI: 10.1016/J.Ejphar.2008.02.097  0.303
1999 Hanania T, Johnson KM. Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors. Brain Research. 844: 106-17. PMID 10536266 DOI: 10.1016/S0006-8993(99)01869-7  0.529
1999 Hanania T, Hillman GR, Johnson KM. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit. Synapse (New York, N.Y.). 31: 229-39. PMID 10029241 DOI: 10.1002/(SICI)1098-2396(19990301)31:3<229::AID-SYN8>3.0.CO;2-3  0.38
1998 Hanania T, Johnson KM. Regulation of neurotransmitter release by endogenous nitric oxide in striatal slices. European Journal of Pharmacology. 359: 111-7. PMID 9832380 DOI: 10.1016/S0014-2999(98)00636-0  0.334
Show low-probability matches.